Mark A. Lovell's Recent Publications

    1

    1.         M.A. Lovell, S. Xiong, W.R. Markesbery and B.C. Lynn, “Quantitative Proteomics Analysis of Mitochondria from Primary Neuron Cultures Treated with Amyloid Beta Peptide,” Neurochem. Res.30, 113-122, 2005.

     

    2.         J.Q. Wang, W.R. Markesbery and M.A. Lovell, “Increased Oxidative Nuclear and Mitochondrial DNA Damage in Alzheimer’s Disease”, J. Neurochem, 93:953-62, 2005.

     

    3.         T.I. Williams, M.A. Lovell, and B.C. Lynn, “Analysis of derivatized biogenic aldehydes by HPLC tandem mass spectrometry”, Anal. Chem., 77:3383-3389,2005.

     

    4.         M.A. Lovell and W.R. Markesbery, “Ectopic Expression of Musashi-1 in Alzheimer Disease and Pick Disease”, J. Neuropath. Exp. Neurol., 64:1-6, 2005.

     

    5.         M.A. Lovell, J.L. Smith, S. Xiong, and W.R. Markesberyl, “Alterations in Zinc Transporter Protein-1 (ZnT-1) in Mild Cognitive Impairment, Early and Late-Stage Alzheimer’s Disease Brain,” Neurotox. Res., 7:265-271, 2005.

     

    6.         X.L. Liu, B.C. Lynn, W.R. Markesbery, and M.A. Lovell, “Acrolein Guanine Adducts are Elevated in Alzheimer’s Disease Brain”, Anal. Chem., 77:5982-5989, 2005.

     

    7.         C.D. Smith, G.R. Umberger, R.J. Kryscio, F.A. Schmitt, M.A. Lovell, L.X. Blonder, and A.H. Anderson, “Longitudinal Functional Brain Alterations in Asymptomatic Women at Risk for Alzheimer’s Disease”, J. Neuroimaging, 15:271-277, 2005.

     

    8.         J.L. Smith, S. Xiong, W.R. Markesbery and M.A. Lovell, “4-Hydroxynonenal Disrupts Zinc Transport in Primary Rat Cortical Neurons”, Neurosci. Lett., In Press, 2005.

     

    9.         M.A. Lovell, H. Geiger, G.E. VanZant, B.C. Lynn and W.R. Markesbery, “Neural Precursor Cells from Alzheimer’s Disease and Aged Control Brain,”  Neurobiol. Aging, In Press, 2005.

     

    10.       J. Wang, W.R. Markesbery and M.A. Lovell, “Increased DNA  Oxidation in Mild Cognitive Impairment”, J. Neurochem., In Press, 2005. 

     

    11.       W.R. Markesbery, R.J. Kryscio, M.A. Lovell, and J.D. Morrow.  “Lipid Peroxidation is an Early Event in the Brain in Amnestic Mild Cognitive Impairment”, Ann. Neurol. , In Press, 2005. 

     

    12.       M.A. Lovell, J.L. Smith and W.R. Markesbery, “Elevated ZnT-6 in Mild Cognitive Impairment, Alzheimer’s Disease and Pick’s Disease”, J. Neuropathol. Exp. Neurol., In Press, 2005. 

     

    13.       C.X. Shao, K.N. Roberts, K.M. Miller, W.R. Markesbery, S.W. Scheff and M.A. Lovell,  “Oxidative Stress in Head Trauma in Aging”, Free Radic Biol. Med., In press, 2005.

     

    14.       M.A. Lovell, J.Q. Wang, W.R. Markesbery and B.C. Lynn, “Changes in the Mitochondrial Proteome in Alzheimer’s Disease Brain”, Mol. Cell. Proteomics, Submitted for publication, 2005.

     

    15.       J.L Smith, W.R. Markesbery and M.A. Lovell, “Alterations in Zinc Transporters ZnT-4 and ZnT-6 in Alzheimer’s Disease”, Neuroscience., In Press, 2005.

     

    16.       M.A. Lovell, S. Xiong, C.S. Xie, P. Davies and W.R. Markesbery, “Induction of Hyperphosphorylated Tau in Primary Rat Cortical Neuron Cultures Mediated by Glycogen Synthase Kinase-3,”  J. Alzheimer’s. Disease, 6, 659-671, 2004.

     

    17.       J. Drake, R. Petroze, A. Castegna, Q. Ding, J.N. Keller, W.R. Markesbery, M.A. Lovell and D.A. Butterfield, “4-Hydroxynonenal Oxidatively Modifies Histones:  Implications for Alzheimer’s Disease”, Neurosci. Lett. 356, 155-158, 2004.

     

    18.       P.G. Sullivan, A. G. Rabchevsky, J.N. Keller, M.A. Lovell, A. Sodhi, R.P. Hart and S.W. Scheff, “Intrinsic Differences in Brain and Spinal Cord Mitochondria:  Implications for Therapeutic Interventions”, J. Comp. Neurology, 474, 524-534, 2004.

     

    19.       B.R. Wenner, M.A. Lovell, and B.C. Lynn, “Proteomic Analysis of Human Ventricular Cerebrospinal Fluid from Neurologically Normal Elderly Subjects Using Two-Dimensional LC-MS/MS,” J. Proteome Res., 3, 97-103, 2004.

     

     

BOOK CHAPTERS

    1

    1.      J.D. Robertson and M.A. Lovell, “Applications of Radioanalytical Chemistry to Alzheimer’s Disease”, In:  Radioanalytical Methods in Interdisciplinary Research, C.A. Laue and K.L. Nash, Eds., 2004, pp. 298-306.

     

    2.       M. A. Lovell and W. R. Markesbery, "Analysis of Aldehydic Markers of Lipid Peroxidation in Biological Tissues by High-Pressure Liquid Chromatography with Fluorescence Detection," In:  Methods in Biological Oxidative Stress, K. Hensley, Ed., 2003.

     

    3.     W. R. Markesbery, T. J. Montine and M. A. Lovell, "Oxidative Alteration in Neurodegenerative Diseases," In:  The Pathogenesis of Neurodegenerative Disorders, M. P. Mattson, Ed., Humana Press, 2001.

     

    4.     M. A. Lovell, W. D. Ehmann, W. R. Markesbery, S. Melethil, C. R. Swyt and P. F. Zatta, "Standardization in Biological Analyses of Aluminum:  What are the Needs?" In:  Research Issues in Aluminum Toxicity, R. A. Yokel and M. S. Golub, Eds., Taylor and Francis, 1997.